NEUREXIS THERAPEUTICS
Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.
NEUREXIS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Neuroscience
Founded:
2020-01-01
Address:
Aurora, Colorado, United States
Country:
United States
Website Url:
http://www.neurexistherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
720-771-6670
Email Addresses:
[email protected]
Total Funding:
305 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Embrace Scar Therapy
Embrace Scar Therapy develops tissue repair devices for plastic surgery to minimize scar formation.
Current Employees Featured
Investors List
Colorado Office of Economic Development and International Trade
Colorado Office of Economic Development and International Trade investment in Grant - Neurexis Therapeutics
VIC Technology Venture Development
VIC Technology Venture Development investment in Seed Round - Neurexis Therapeutics
Official Site Inspections
http://www.neurexistherapeutics.com
- Host name: jib.gcmcomputers.com
- IP address: 148.59.95.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neurexis Therapeutics"
Home - neurexistherapeutics.com
Neurexis is developing tatCN19o, an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia. Stay up to date with Neurexis Therapeutics, Subscribe to the VIC newsletter. …See details»
Neurexis Therapeutics - Crunchbase Company Profile & Funding
Neurexis Therapeutics provides stroke and cardiac arrest treatments. They offer treatments for cerebral ischemia, sickle cell anemia, congenital heart defects, vascular surgery, and pre …See details»
Neurexis Therapeutics - LinkedIn
Neuroprotective Innovation for Human Health | Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.See details»
About - neurexistherapeutics.com
Dr. Artinger has over 23 years of operational experience in the life science industry and as been involved in the preclinical and clinical development of therapeutics and vaccines across multiple therapeutic areas.See details»
Overview: www.neurexistherapeutics.com and degenerative …
Overview: Neurexis Therapeutics was formed in early 2020 to develop a new medication for the prevention of brain damage following ischemic events such as cardiac arrest and stroke, as …See details»
Neurexis Therapeutics - Overview, News & Similar companies
Apr 19, 2023 · View Neurexis Therapeutics (www.neurexistherapeutics.com) location in Colorado, United States , revenue, industry and description. Find related and similar companies as well …See details»
Neurexis Therapeutics - VIC Network
Neurexis Therapeutics was formed in early 2020 to develop a new medication for the prevention of brain damage following ischemic events such as cardiac arrest and stroke.See details»
Neurexis Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Neurexis Therapeutics.See details»
News - neurexistherapeutics.com
September 18, 2024 – Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II …See details»
Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to …
Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of Neurological Disorders and Stroke (NINDS). The grant will …See details»
VIC Technology Venture Development Forms New Portfolio …
AURORA, CO - VIC Technology Venture Development, LLC (VIC) announced today the formation of Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage …See details»
Neurexis Therapeutics - VentureRadar
Website: https://neurexistherapeutics.com/ Develops tatCN19o, an optimized peptide for treating global cerebral ischemia, aiming to reduce brain damage and address a market gap. …See details»
Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis …
Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II Small Business Innovation Research (SBIR) grant through …See details»
Technology - neurexistherapeutics.com
Neurexis is currently pursuing preclinical development of tatCN19o. Technology TatCN19o is a 30 amino acid peptide that includes two functional domains. The first domain facilitates the ability …See details»
Neurexis Therapeutics: New Discoveries Could Revolutionize
AURORA, Colo., Sept. 20, 2023 /PRNewswire-PRWeb/ -- Neurexis Therapeutics, a biotechnology company committed to reshaping the landscape of neuroprotection, is excited to highlight …See details»
From the Corner Office: Neurexis Therapeutics - VIC Tech
With this funding in place, we will be able to accelerate entry into clinical testing of tatCN19o in healthy patients in a Phase Ia study, with the ultimate goal of generating efficacy data in …See details»
Neurexis Therapeutics Created to Focus on Neuroprotective …
AURORA, Colo., April 22, 2020 /PRNewswire-PRWeb/ -- VIC Technology Venture Development, LLC (VIC) announced today the formation of Neurexis Therapeutics, Inc. to develop a new …See details»
Chief Executive Officer and Board Member - Crunchbase
Michael Artinger is the Co-Founder and Board Member at Zebra Analytix. He is also the Chief Executive Officer at Neurexis Therapeutics. He earned his bachelor's and doctorate degree at …See details»
Neurexis Therapeutics Secures $3 Million NIH Grant to Advance ...
Aurora, CO - Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II …See details»
Neurexis Therapeutics: New Discoveries Could Revolutionize …
Aurora, CO - Neurexis Therapeutics, a biotechnology company committed to reshaping the landscape of neuroprotection, is excited to highlight recent groundbreaking research that could …See details»